These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 6069848)
61. The effects of p-chlorophenylalanine and phenylalanine on brain ester-bound fatty acids of developing rats. Foote JL; Tao RV Life Sci; 1968 Nov; 7(22):1187-92. PubMed ID: 5752507 [No Abstract] [Full Text] [Related]
62. Atypical phenylketonuric heterozygote. Deficiency in phenylalanine hydroxylase and transaminase activity. Anderson JA; Fisch R; Miller E; Doeden D J Pediatr; 1966 Mar; 68(3):351-60. PubMed ID: 4379218 [No Abstract] [Full Text] [Related]
63. Characteristics of the hepatic phenylalanine-hydroxylating system in newborn rats. Brenneman AR; Kaufman S J Biol Chem; 1965 Sep; 240(9):3617-22. PubMed ID: 5891076 [No Abstract] [Full Text] [Related]
64. The effects of L-phenylalanine and phenylpyruvate on glycolysis in rat cerebral cortex. Glazer RI; Weber G Brain Res; 1971 Oct; 33(2):439-50. PubMed ID: 5167448 [No Abstract] [Full Text] [Related]
65. Renal transport of aromatic acids in patients with phenylketonuria. Langenbeck U; Behbehani A; Luthe H J Inherit Metab Dis; 1981; 4(2):69-70. PubMed ID: 6790852 [TBL] [Abstract][Full Text] [Related]
66. Behavioral and biochemical correlates of diet change in phenylketonuria. Anderson VE; Siegel FS Pediatr Res; 1976 Jan; 10(1):10-7. PubMed ID: 1246460 [TBL] [Abstract][Full Text] [Related]
67. A learning impairment associated with induced phenylketonuria. Butcher R; Vorhees C; Berry H Life Sci I; 1970 Nov; 9(22):1261-8. PubMed ID: 5530605 [No Abstract] [Full Text] [Related]
68. Inhibition of phenylalanine hydroxylation during treatment of carcinoid syndrome with p-chlorophenylalanine. Szeinberg A; Shani M; Crispin M; Hirshorn N; Cohen BE; Sheba C Isr J Med Sci; 1970; 6(4):475-8. PubMed ID: 5472331 [No Abstract] [Full Text] [Related]
69. Behavioral and biochemical effects of p-chlorophenylalanine, 3-chlorotyrosine and 3-chlorotyramine. A proposed mechanism for inhibition of self-stimulation. Stark P; Fuller RW Neuropharmacology; 1972 Mar; 11(2):261-72. PubMed ID: 4260269 [No Abstract] [Full Text] [Related]
70. [Utilization of excess phenylalanine in the diet of rats to obtain an experimental model of phenylketonuria]. Isacheva NT; Ekimovskiĭ AP Vopr Pitan; 1975; (1):40-4. PubMed ID: 1239862 [TBL] [Abstract][Full Text] [Related]
71. Another population of phenylketonuria? Studies on atypical phenylketonurics. Culley PD Dev Med Child Neurol; 1969 Dec; 11(6):718-29. PubMed ID: 5366192 [No Abstract] [Full Text] [Related]
72. [Study of the metabolism of an enzymatic system in phenylketonuria]. Goncerzewicz M Rev Med Liege; 1966 Jan; 21(1):1-6. PubMed ID: 5901976 [No Abstract] [Full Text] [Related]
79. Relationship between myelin production and dopamine synthesis in the PKU mouse brain. Joseph B; Dyer CA J Neurochem; 2003 Aug; 86(3):615-26. PubMed ID: 12859675 [TBL] [Abstract][Full Text] [Related]
80. Experimentally induced phenylketonuria. I. Inhibitors of phenylalanine hydroxylase. DeGraw JI; Cory M; Skinner WA; Theisen MC; Mitoma C J Med Chem; 1967 Jan; 10(1):64-6. PubMed ID: 6069058 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]